-
June 04, 2012
New York, June 4th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) closed the trading session at ...
-
May 17, 2012
It was revealed on Thursday that Human Genome Sciences (NASDAQ: HGSI) is in talks with, in its own words "major" ...
-
May 09, 2012
It's a sad fact that diabetes is becoming an increasingly commonplace disease, so at least it's encouraging that ...
-
May 09, 2012
Wednesday, May 9, 2012
It's all about Greece. Today's trading action may not be as volatile as the one on ...
-
May 03, 2012
The pharmaceutical giant reported decent first quarter results late in April 2012. However, It will likely be some ...
-
April 26, 2012
There’s no one place for growth any longer, so it pays to diversify across world markets and few funds do it ...
-
April 24, 2012
When the pharmaceutical giant GlaxoSmithKline stepped up to the plate with a $13 a share offer for Human Genome ...
-
April 11, 2012
The risks are huge, but well worth the potential rewards, writes MoneyShow.com senior editor Igor Greenwald. ...
-
April 04, 2012
These three big drug stocks offer attractive yields and relative safety heading into the more challenging summer ...
-
January 27, 2012
The healthcare giant reported impressive results in 2011 and offers a reasonable valuation and solid dividends.
-
December 29, 2011
2011 was a surprisingly healthy year for drug stocks.
-
November 30, 2011
When a company like Novartis comes down the road with a healthy pipeline, the Street seems to respond with worries.
-
November 22, 2011
Gilead is going all in on Hep C, as it acquires Pharmasset in a massive deal.
-
September 30, 2011
Learn more about three large pharmaceutical companies with the highest current yields.
-
September 23, 2011
Despite its inflationary pressures, India's strength and investment potential continues to grow.
-
September 21, 2011
Vivus takes a more pragmatic approach to getting Qnexa to market.
-
August 17, 2011
In the wake of big pharma's patent cliff and slowing R&D spending, the biotech sector is looking good for investors.
-
August 02, 2011
Selecting from the top dividend stocks owned by professional investors may give your portfolio a boost.
-
July 19, 2011
Vical gets a small victory with a partnership for its CMV drug.
-
July 15, 2011
Transcept gets a major setback, but it may not be doomed.
